About Midwest Physicians Group
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Midwest Physicians Group
During the past decade, Midwest Physicians Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
1995-12-01
2010-02-01
Completed
2,411
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
1999-05-01
2014-02-01
Completed
5,611
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
1999-02-01
2008-09-22
Completed
22
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
2004-06-01
2012-02-01
Completed
806
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Midwest Physicians Group
According to Clinical.Site data, the most researched conditions in "Midwest Physicians Group" are
"Breast Cancer" (1 trials), "Breast Tumor" (1 trials), "Cancer of the Breast" (1 trials), "Estrogen Receptor- Negative Breast Cancer" (1 trials) and "HER2- Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Midwest Physicians Group" in a lesser frequency.
Clinical Trials Intervention Types at Midwest Physicians Group
Most popular intervention types in "Midwest Physicians Group" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "TF0023" (1 trials) and "nab-Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Midwest Physicians Group
The vast majority of trials in "Midwest Physicians Group" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Midwest Physicians Group
Currently, there are NaN active trials in "Midwest Physicians Group".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Midwest Physicians Group,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Midwest Physicians Group, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".